Masimo | MASI - Ebitda

Stock Price
178.47
Daily Change
0.12 0.07%
Monthly
0.10%
Yearly
14.68%
Q2 Forecast
174.62

Masimo reported $85.5M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Accuray USD -685K 900K Sep/2024
Align Technology USD 260.87M 77.03M Dec/2025
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Avanos Medical USD 13M 3M Dec/2025
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
General Electric Aerospace USD 2.84B 568M Mar/2026
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 94.78M 20.75M Dec/2025
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
Masimo USD 85.5M 6.4M Mar/2026
Medtronic USD 2.93B 482M Dec/2025
Orthofix International USD 27.88M 2.77M Dec/2025
Owens Minor USD 90.02M 2.15M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 394.7M 5M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025